Wechselwirkungen · Betaferon
Betaferon 250 microgram/ml, powder and solvent for solution for injection · Abschnitt 4.5 · PDF-Seite 7
HOS-085139 · Präparat HOS-083087
Interferons have been reported to reduce the activity of hepatic cytochrome P450-dependent enzymes in humans and animals. Caution should be exercised when Betaferon is administered in combination with medicinal products that have a narrow therapeutic index and are largely dependent on the hepatic cytochrome P450 system for clearance, e.g. anti-epileptics. Additional caution should be exercised with any co-medication which has an effect on the haematopoietic system.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-11-24T11:42:00Z · SHA-256 73002d6eb728583b13eb94f0947d2c951ea9003845f9750afc924bebe2f83959 · Passage 09ba9925e12c3b93e552ff2f3ae46a9f55122c2c7a0fca54da2d11f91a901fe1 · Zeichen 508–977 im Abschnitt